parol-pedifen@dafra.be

Dafra Pharma markets Parol®, a high-quality paracetamol, produced according to the strictest European criteria.

Parol® is indicated for the treatment of mild to moderate pain and fever.

Parol® is very popular because it has fewer  contraindications   than other analgesics and enjoys a good public image.

Parol® is a very effective drug with a good benefit/risk ratio. The main precaution to be taken, valid for all patients, is not to exceed the maximum authorized dose (4g/day for adults or 60 mg/kg per day for children), so as not to reach concentrations which term can be dangerous for the liver.

​

This is also the reason why it is also necessary to respect the recommended intervals between doses: in adults, it is necessary to wait 4 hours after taking 500 mg and 6 hours after taking one gram; in children, care must be taken to distribute the doses over the whole of 24 hours, i.e. one dose every 6 hours of 10 mg/kg.

MODE OF ACTION OF SPEECH

​

Parol® acts by inhibiting the synthesis of prostaglandins which are the mediators of fever and pain. Parol® is used in the symptomatic treatment of pain and fever. This implies that Parol® relieves symptoms, but does not cure. Within half an hour after use, it can be noticed that pains and fever as well as pains (such as headaches, sore throats and others) decrease. This effect lasts for three to six hours.

​

Parol® (paracetamol) is recognized for its good tolerance. In particular, it causes little or no irritation to the gastrointestinal tract. Its use is allowed during pregnancy and lactation. The main precaution is to avoid overdose, which is toxic to the liver.